Petrus Bekker, SVP of Medical & Clinical at ChemoCentryx, Inc. (CCXI), sold 4,800 shares at $14.00 ($67K) on 2013-05-24, disclosed to the SEC on 2013-05-28.
Scheduled sale ($67k) by SVP of Medical & Clinical under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.00 | 4,718 | $66K | 98.3% |
| 2 | $14.00 | 82 | $1K | 1.7% |
| Total | $14.00 avg | 4,800 | $67K | 100% |
| Filing → |
| CCXI | SELL | 2017-06-30 | $760K | — | Filing → |
| CCXI | SELL | 2016-12-20 | $134K | — | Filing → |
| CCXI | SELL | 2016-12-07 | $255K | — | Filing → |